Adverum Biotechnologies, Inc.
ADVMDelisted Dec 9, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501756
Adverum Biotechnologies, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 10, 2025; 50 institutions reported holding it in 13F filings for Q3 2025, worth $63.8M in total; no superinvestor held it.
Q1 2025 vs. Q4 2024
How the institutions holding Adverum Biotechnologies, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 70 | 1 | 71 | +2 |
| Shares | 15.9M | 172.4K | 16.3M | +635.4K (+4.0%) |
| Value | $74.1M | $805.3K | $69.8M | −$3.51M (−4.8%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Warren Averett Asset Management, LLC | 160,165 | $699.9K | 0.01% |
| Invesco Ltd. | 49,831 | $217.8K | 0.00% |
| Susquehanna International Group, LLP | 37,334 | $163.2K | 0.00% |
| AQR Capital Management LLC | 33,823 | $147.8K | 0.00% |
| Nuveen, LLC | 31,847 | $139.2K | 0.00% |
| Intech Investment Management LLC | 12,400 | $54.2K | 0.00% |
| Captrust Financial Advisors | 10,624 | $46.4K | 0.00% |
| Russell Investments Group, Ltd. | 1,375 | $6.01K | 0.00% |
| Eq Wealth Advisors, LLC | 162 | $708 | 0.00% |
| Rothschild Investment LLC | 100 | $437 | 0.00% |
| EverSource Wealth Advisors, LLC | 7 | $31 | 0.00% |
Sold out (9)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Citadel Advisors LLC | 149,071 | $696.2K |
| Marshall Wace, LLP | 98,027 | $457.8K |
| Millennium Management LLC | 42,847 | $200.1K |
| Corton Capital Inc. | 32,696 | $152.7K |
| Connor, Clark & Lunn Investment Management Ltd. | 18,261 | $85.3K |
| HSBC Holdings PLC | 10,704 | $48.7K |
| R Squared Ltd | 710 | $3.32K |
| Caitong International Asset Management Co., Ltd | 44 | $205 |
| Lazard Asset Management LLC | 17 | $0 |
Not filed for Q1 2025 yet (1)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 172,437 | $805.3K |